Applied Therapeutics
APLT
APLT was delisted on the 2nd of February, 2026.
69 hedge funds and large institutions have $319M invested in Applied Therapeutics in 2021 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 29 increasing their positions, 13 reducing their positions, and 8 closing their positions.
123% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 13
25% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 8
15% more capital invested
Capital invested by funds: $278M → $319M (+$40.7M)
3% more funds holding
Funds holding: 67 → 69 (+2)
1.82% more ownership
Funds ownership: 57.11% → 58.93% (+1.8%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
72% less call options, than puts
Call options by funds: $423K | Put options by funds: $1.53M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$3.68M |
| 2 |
BlackRock
New York
|
+$2.05M |
| 3 |
Franklin Resources
San Mateo,
California
|
+$1.53M |
| 4 |
First Manhattan
New York
|
+$1.4M |
| 5 |
Russell Investments Group
London,
United Kingdom
|
+$1.03M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.14M |
| 2 |
MS
Maven Securities
St Helier,
Jersey
|
-$950K |
| 3 |
AA
AlphaCentric Advisors
San Juan,
Puerto Rico
|
-$619K |
| 4 |
California Public Employees Retirement System
Sacramento,
California
|
-$520K |
| 5 |
Millennium Management
New York
|
-$363K |
APLT Hedge Fund Activity: Q2 2021 in Review
69 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Applied Therapeutics (APLT) for Q2 2021, worth a combined $319M — up 15% from $278M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new APLT positions and 8 closed out — a net gain of 2 holders — while 29 added to existing stakes and 13 trimmed.
The largest buyer was Point72 Asset Management, adding an estimated $3.68M. The largest seller was Fidelity Investments, cutting an estimated $2.14M.
- 69 institutional investors held Applied Therapeutics (APLT) as of Q2 2021, up from 67 in Q1 2021.
- Funds reported $319M of Applied Therapeutics stock for Q2 2021, up 15% quarter-over-quarter.
- 10 funds opened new Applied Therapeutics positions in Q2 2021 and 8 closed out, a net change of +2 holders.
- The largest Applied Therapeutics buyer in Q2 2021 was Point72 Asset Management, an estimated $3.68M added.
- The largest Applied Therapeutics seller in Q2 2021 was Fidelity Investments, an estimated $2.14M sold.
Based on aggregated 13F filings for Q2 2021.